GURUFOCUS.COM » STOCK LIST » Technology » Software » Evolear AB (XSAT:EVOL) » Definitions » ROE %

Evolear AB (XSAT:EVOL) ROE % : -572.58% (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Evolear AB ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Evolear AB's annualized net income for the quarter that ended in Dec. 2024 was kr-28.09 Mil. Evolear AB's average Total Stockholders Equity over the quarter that ended in Dec. 2024 was kr4.91 Mil. Therefore, Evolear AB's annualized ROE % for the quarter that ended in Dec. 2024 was -572.58%.

The historical rank and industry rank for Evolear AB's ROE % or its related term are showing as below:

XSAT:EVOL' s ROE % Range Over the Past 10 Years
Min: -330.79   Med: -20.9   Max: Negative Equity
Current: -300.63

During the past 8 years, Evolear AB's highest ROE % was Negative Equity%. The lowest was -330.79%. And the median was -20.90%.

XSAT:EVOL's ROE % is ranked worse than
97.04% of 2604 companies
in the Software industry
Industry Median: 4.52 vs XSAT:EVOL: -300.63

Evolear AB ROE % Historical Data

The historical data trend for Evolear AB's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evolear AB ROE % Chart

Evolear AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE %
Get a 7-Day Free Trial -26.70 0.01 Negative Equity -330.79 -191.39

Evolear AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -137.82 -230.56 -260.71 -153.14 -572.58

Competitive Comparison of Evolear AB's ROE %

For the Software - Application subindustry, Evolear AB's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evolear AB's ROE % Distribution in the Software Industry

For the Software industry and Technology sector, Evolear AB's ROE % distribution charts can be found below:

* The bar in red indicates where Evolear AB's ROE % falls into.



Evolear AB ROE % Calculation

Evolear AB's annualized ROE % for the fiscal year that ended in Dec. 2024 is calculated as

ROE %=Net Income (A: Dec. 2024 )/( (Total Stockholders Equity (A: Dec. 2023 )+Total Stockholders Equity (A: Dec. 2024 ))/ count )
=-11.581/( (4.122+7.98)/ 2 )
=-11.581/6.051
=-191.39 %

Evolear AB's annualized ROE % for the quarter that ended in Dec. 2024 is calculated as

ROE %=Net Income (Q: Dec. 2024 )/( (Total Stockholders Equity (Q: Sep. 2024 )+Total Stockholders Equity (Q: Dec. 2024 ))/ count )
=-28.088/( (1.831+7.98)/ 2 )
=-28.088/4.9055
=-572.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2024) net income data. ROE % is displayed in the 30-year financial page.


Evolear AB  (XSAT:EVOL) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2024 )
=Net Income/Total Stockholders Equity
=-28.088/4.9055
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-28.088 / 0.8)*(0.8 / 21.2125)*(21.2125 / 4.9055)
=Net Margin %*Asset Turnover*Equity Multiplier
=-3511 %*0.0377*4.3242
=ROA %*Equity Multiplier
=-132.36 %*4.3242
=-572.58 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2024 )
=Net Income/Total Stockholders Equity
=-28.088/4.9055
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-28.088 / -28.08) * (-28.08 / -4.256) * (-4.256 / 0.8) * (0.8 / 21.2125) * (21.2125 / 4.9055)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.0003 * 6.5977 * -532 % * 0.0377 * 4.3242
=-572.58 %

Note: The net income data used here is four times the quarterly (Dec. 2024) net income data. The Revenue data used here is four times the quarterly (Dec. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Evolear AB ROE % Related Terms

Thank you for viewing the detailed overview of Evolear AB's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Evolear AB Business Description

Traded in Other Exchanges
N/A
Address
Karolinska Institutet Science Park, Fogdevreten 2, Solna, SWE, SE-171 65
Evolear AB is an ed-tech company that offers a wide range of educational games and applications through its brands Evolear, 10Monkeys, TalesTime and MyFirstApp worldwide. Its commitment is to promote children's learning and development in areas such as mathematics, language and cognitive skills, by providing fun and interactive tools adapted to different ages and developmental stages.